Identification of Residues of SARS-CoV nsp1 That Differentially Affect Inhibition of Gene Expression and Antiviral Signaling

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Jauregui, Andrew R ^a   Savalia, Dhruti ^a   Lowry, Virginia K ^a   Farrell, Cara M ^a   Wathelet, Marc G ^a,b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 3; NONSTRUCTURAL PROTEIN 1;

ALPHA HELIX; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; INNATE IMMUNITY; MUTAGENESIS; PHENOTYPE; PLASMID; PLEIOTROPY; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS MORPHOLOGY;

AMINO ACID SEQUENCE; AMINO ACIDS; BETA-GALACTOSIDASE; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNE EVASION; LUCIFERASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; RNA REPLICASE; SARS VIRUS; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 84876945545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062416     Document Type: Article

References (45)

1. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Agol V, Gmyl A, (2010) Viral security proteins: counteracting host defences. Nat Rev Microbiol 8: 867-878.
3. Sen G, (2001) Viruses and interferons. Annu Rev Microbiol 55: 255-281.
4. Haller O, Kochs G, Weber F, (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
5. Versteeg G, García-Sastre A, (2010) Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13: 508-516.
6. Brian D, Baric R, (2005) Coronavirus genome structure and replication. Curr Top Microbiol and Immunol 287: 1-30.
7. Perlman S, Netland J, (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7: 439-450.
8. Wevers B, van der Hoek L (2009) Recently discovered human coronaviruses. Clin Lab Med: 715-724.
9. Woo P, Lau S, Huang Y, Yuen K-Y, (2009) Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med 234: 1117-1127.
10. Osterhaus A, Fouchier R, Kuiken T, (2004) The aetiology of SARS: Koch's postulates fulfilled. Philos Trans R Soc B Biol Sci 359: 1081-1082.
11. van der Hoek L, Pyrc K, Jebbink M, Vermeulen-Oost W, Berkhout R, et al. (2004) Identification of a new human coronavirus. Nat Med 10: 368-373.
12. Woo P, Lau S, Chu C-M, Chan K-H, Tsoi H-W, et al. (2005) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79: 884-895.
13. Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, et al. (2006) Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A 103: 12885-12890.
14. Kopecky-Bromberg S, Martínez-Sobrido L, Frieman M, Baric R, Palese P (2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol., 81, 548-57.
15. Frieman M, Yount B, Heise M, Kopecky-Bromberg S, Palese P, et al. (2007) Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol 81: 9812-9824.
16. Wathelet MG, Orr M, Frieman MB, Baric RS, (2007) Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 81: 11620-11633.
17. Fang X, Gao J, Zheng H, Li B, Kong L, et al. (2007) The membrane protein of SARS-CoV suppresses NF-kappaB activation. J Med Virol 79: 1431-1439.
18. Devaraj S, Wang N, Chen Z, Chen Z, Tseng M, et al. (2007) Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 282: 32208-32221.
19. Minakshi R, Padhan K, Rani M, Khan N, Ahmad F, et al. (2009) The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor. PLoS ONE 4(12): e8342.
20. Frieman M, Ratia K, Johnston R, Mesecar A, Baric R, (2009) Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol 83: 6689-6705.
21. Siu K-L, Kok K-H, Ng M-H, Poon V, Yuen K-Y, et al. (2009) Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem 284: 16202-16209.
22. Lu X, Pan J, Tao J, Guo D (2010) SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes, 42, 37-45.
23. Li S-W, Lai C-C, Ping J-F, Tsai F-J, Wan L, et al. (2011) Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways. J Gen Virol 92: 1127-1140.
24. Sun L, Xing Y, Chen X, Zheng Y, Yang Y, et al. (2012) Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS ONE 7(2): e30802.
25. Narayanan K, Huang C, Lokugamage K, Kamitani W, Ikegami T, et al. (2008) Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol 82: 4471-4479.
26. Kamitani W, Huang C, Narayanan K, Lokugamage K, Makino S, (2009) A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol 16: 1134-1140.
27. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, et al. (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1: 507-518.
29. Yang H, Lin C, Ma G, Orr M, Baffi M, et al. (2002) Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur J Biochem 269: 6142-6151.
30. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
31. Abramoff MD, Magalhaes PJ, Ram SJ, (2004) Image Processing with ImageJ. Biophot Intern 11: 36-42.
32. Almeida M, Johnson M, Herrmann T, Geralt M, Wüthrich K, (2007) Novel beta-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus. J Virol 81: 3151-3161.
33. Wang Y, Shi H, Rigolet P, Wu N, Zhu L, et al. (2010) Nsp1 proteins of group I and SARS coronaviruses share structural and functional similarities. Infect Genet Evol 10: 919-924.
34. Züst R, Cervantes-Barragan L, Kuri T, Blakqori G, Weber F, et al. (2007) Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog 3(8): e109.
35. Huang C, Lokugamage K, Rozovics J, Narayanan K, Semler B, et al. (2011) SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog 7(12): e1002433.
36. Pfefferle S, Schöpf J, Kögl M, Friedel C, Müller M, et al. (2011) The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. PLoS Pathog 7(10): e1002331.
37. Turoverov K, Kuznetsova I, Uversky V, (2010) The protein kingdom extended: ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation. Prog Biophys Mol Biol 102: 73-84.
38. Spiegel M, Pichlmair A, Martínez-Sobrido L, Cros J, García-Sastre A, et al. (2005) Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79: 2079-2086.
39. Gough D, Messina N, Clarke C, Johnstone R, Levy D, (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
40. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung I-F, et al. (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361: 1767-1772.
41. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, et al. (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95-103.
42. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, et al. (2005) An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75, 185-194.
43. Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, et al. (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79: 7819-7826.
44. Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, et al. (2005) Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106: 2366-2374.
45. Reghunathan R, Jayapal M, Hsu L-Y, Chng H-H, Tai D, et al. (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 6: 2-12.